Symetryx Corp

Insider Reports History

Location
Toronto, Ontario, Canada
Signature
Barry Shiff
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Symetryx Corp:

Company Role Class Num Shares Value Price $ Report Date Ownership
NeuBase Therapeutics, Inc. 10%+ Owner Common Stock, par value $0.0001 192,481 $369,564 $1.92 18 Sep 2023 Direct
NeuBase Therapeutics, Inc. 10%+ Owner Common Stock, Par Value $0.0001 per Share 0 $1.19 18 Sep 2023 Direct

Insider Reports Filed by Symetryx Corp

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000199192523000005-symetryx-corp-2023-09-14 NeuBase Therapeutics, Inc. 14 Sep 2023 3 -$375,620 4 10%+ Owner 18 Sep 2023, 16:32
/report/000199192523000003-symetryx-corp-2023-09-07 NeuBase Therapeutics, Inc. 07 Sep 2023 3 -$336,731 4 10%+ Owner 11 Sep 2023, 17:08
/report/000199192523000002-symetryx-corp-2023-09-01 NeuBase Therapeutics, Inc. 01 Sep 2023 1 +$59,732 4 10%+ Owner 07 Sep 2023, 17:19
/report/000199192523000004-symetryx-corp-2023-08-23-restatement NeuBase Therapeutics, Inc. 23 Aug 2023 0 $0 3/A 10%+ Owner 12 Sep 2023, 17:20
/report/000199192523000006-symetryx-corp-2022-12-31 NeuBase Therapeutics, Inc. 31 Dec 2022 1 $0 5 no longer 10% Owner 20 Sep 2023, 20:42